The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
Infections are the second leading cause of death in cancer patients, after the cancer itself; Zisis Kozlakidis and Shalini Jayasekar Zurn discuss the challenges surrounding the interplay between cancer and antimicrobial resistance (AMR).
Dr Mark Verrill, Consultant Medical Oncologist at the Northern Centre for Cancer Care, discusses the importance of personalised breast cancer treatment.
Long waits for cancer care have become normal across the UK, with nearly half of all specialist cancer centres experiencing delays most weeks, according to the Royal College of Radiologists (RCR).
In a study, researchers from the University of Basel and the University Hospital Basel have uncovered a promising new approach to combat the Epstein-Barr virus (EBV), a common virus that affects 90% of the adult population.
In a significant advancement for breast cancer treatment, a new blood test has shown the ability to predict the recurrence of breast cancer up to three years before tumours become detectable through conventional scans.
The University of Michigan Health Rogel Cancer Center has revealed that changing the dosing schedule for common cancer therapy could greatly reduce greenhouse gas emissions without compromising the patient's outcomes.
63.8% of the UK population are currently overweight or obese. Obesity is a major cause of ill health. Being moderately obese takes around 3 years off your life, whereas severe obesity shortens it by at least 10 years.
Researchers from Oxford Population Health's Cancer Epidemiology Unit have identified specific proteins in the blood that may predict a person's risk of developing various cancers over seven years before diagnosis.
In a recent study, researchers at the University of California San Diego have developed an experimental treatment made from a plant virus that shows effectiveness in protecting against a broad range of metastatic cancers in mice.
Zisis Kozlakidis from the World Health Organization’s International Agency for Cancer and Jiaao Yu from the Shanghai Jiao Tong University discuss the burden of lung cancer in Southeast Asia and China and the priorities for therapies and interventions.
Lorna Rothery spoke to the Cancer Drug Development Forum’s Managing Director, Professor Jaap Verweij and Chairperson of the CDDF Board of Directors, Professor Ruth Plummer, about opportunities and challenges in oncology research and treatment.
A scarcity of suitable therapies and geographic disparities in access to care are impacting survival rates for children with cancer; Lorna Rothery spoke to the European branch of Childhood Cancer International, a pan-European organisation committed to improving outcomes for children and adolescents affected by cancer.
Researchers suggest that microwave ablation, a minimally invasive procedure, could offer comparable progression-free survival rates to surgery with fewer complications.
